Officers

Melinda Richter, Chair
Global Head, Johnson & Johnson Innovation, JLABS

William J. Newell, Vice Chair
Chief Executive Officer, Sutro Biopharma, Inc.

Dirksen Lehman, Treasurer
Corporate Vice President, Public Affairs, Edwards Lifesciences

Beth Roberts, Secretary
Partner, Hogan Lovells US LLP

Members

Wade Ackerman
Partner, Covington & Burling LLP

David Beier, J.D.
Managing Director, Bay City Capital

Victoria H. Blatter
Senior Vice President, U.S. Government Affairs, Amgen

Michael Boyd
Senior Vice President, Government Affairs and Policy, Gilead Sciences

Fritz Bittenbender
Senior Vice President, Access & External Affairs, Genentech

 Josh Brown
National Vice President, State Government Relations, Pfizer

David H. Crean
Managing Partner, Cardiff Advisory, LLC

Kyle W. Gano, Ph.D.
Chief Business Development and Strategy Officer, Neurocrine Biosciences, Inc.

Julie Gilmore, Ph.D.
Site Head and Chief Operating Officer, Lilly Gateway Labs

Mark Ginestro
Principal, Ernst & Young’s Parthenon Strategy Practice

Bryan Giraudo
Chief Finical Officer, Gossamer Bio

Elizabeth Grammer, Esq.
Executive Vice President, General Counsel and Head of Human Resources, Ardelyx, Inc.

Wa’el Hashad
President and CEO, Avanir

Niquette Hunt
CEO, CO-Founder and Board Chair of Candesant Biomedical

Jeff Jonker
Senior Advisor, Ambys Medicines

Andrew G. Kaplan
VP, U.S. Public Affairs, Takeda Pharmaceuticals USA, Inc.

Steve A. Kay, Ph.D., D.Sc.
Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California

John Maddalon
Principal, Life Sciences Practice, Deloitte

Nadir Mahmood 
Chief Financial and Business Officer of Nkarta Therapeutics

Sean McCarthy 
President and Chief Executive Officer, CytomX

Caryn McDowell
Chief Legal and Administrative Officer and Corporate Secretary, Cortexyme, Inc.

Grace Han McMahon
Associate Vice President and Head, Pacific Hub, BD&L

Shlomo Melmed
Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System

Alan Mendelson

Dwight Moxie
General Counsel & Corporate Secretary, Revance Therapeutics, Inc.

Keith Murphy
Founder, CEO, and Chairman, Viscient Biosciences

John Nicols
President and Chief Executive Officer, Codexis

Christian W. Nolet

Joshua J. Ofman, M.D., M.S.H.S.
Chief Medical Officer & External Affairs, GRAIL

Christoph Pittius, Ph.D.
Senior Vice President, Research Business Development, City of Hope

Ganesh Raman, Ph.D.
Associate Vice Chancellor for Research, California State University

Chetana Rao, Ph.D.
Head, Site Strategy & Operations, Bristol-Myers Squibb, Redwood City

Stephen Richardson
Co-Chief Executive Officer, Alexandria Real Estate (ARE)

Wendye Robbins, M.D.
President & CEO, Blade Therapeutics

Mark Roeder
Partner and Former Global Co-Chair, Life Sciences Industry Group, Latham
& Watkins LLP

Daria Mochly-Rosen, Ph.D.
The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine

Terry Rosen, Ph.D.
Chief Executive Officer, Arcus Biosciences

Jennifer Ruddock
Senior Vice President, Strategy & Corporate Affairs, Nektar Therapeutics

Puneet Sarin
Worldwide President, BD Biosciences

George Savage, M.D.
President, Windmill Partners LLC

Paulo Simas
Group President, Managing Partner, Real Chemistry

Lesley Stolz, Ph.D.
Managing Director, Lasana Partners

Elizabeth Thompson, Ph.D.
Group Vice President, Development and External Search, Horizon Therapeutics

Robin Toft
Founder and President, Toft Group Executive Search, a ZRG Company

Mohit Trikha, Ph.D.
Vice President, Head of Oncology Early Development, AbbVie

Harold E. Van Wart, Ph.D.

Bridget Walsh
Vice-President, Government Affairs and Public Policy, Boehringer Ingelheim

Jared Watkin
Senior Vice President, Diabetes Care, Abbott

Katie Wechsler
Partner, Life Sciences, KPMG

Rick E Winningham
Chairman and CEO, Theravance Biopharma

Alice Zhang
CEO & Founder, Verge Genomics